Camp4 Therapeutics Corp
Recent Filings
All 144 filings →| Form | Description | Date |
|---|---|---|
| 8-K | 8-K | Mar 24, 2026 |
| SCHEDULE 13D/A | — | Mar 11, 2026 |
| S-8 | S-8 | Mar 5, 2026 |
| 10-K | 10-K | Mar 5, 2026 |
| 8-K | 8-K | Mar 5, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| SCHEDULE 13G/A | — | Feb 5, 2026 |
| 8-K | 8-K | Jan 9, 2026 |
| SCHEDULE 13D/A | — | Dec 23, 2025 |
| 8-K | 8-K | Dec 23, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Schwab Andrew J. | — | Award / Grant | 2,941,176 @ $1.53 | 2,941,176 | Sep 11, 2025 |
| 5AM Ventures VII, L.P. | — | Purchase | 2,941,176 @ $1.53 | 2,941,176 | Sep 11, 2025 |
| Polaris Management Co. VII, L.L.C. | — | Purchase | 1,221,721 @ $1.53 | 2,825,500 | Sep 11, 2025 |
| Nashat Amir | — | Purchase | 85,468 @ $1.53 | 197,661 | Sep 11, 2025 |
| Maricich Yuri | Chief Medical Officer | Purchase | 6,060 @ $1.65 | 6,060 | Sep 11, 2025 |
| Gold Kelly | Chief Financial Officer | Purchase | 6,060 @ $1.65 | 67,877 | Sep 11, 2025 |
| Mandel-Brehm Josh | Chief Executive Officer | Purchase | 6,060 @ $1.65 | 278,417 | Sep 11, 2025 |
| Young Richard A | — | Purchase | 15,151 @ $1.65 | 170,010 | Sep 11, 2025 |
| Northpond Ventures II, LP | — | Purchase | 763,636 @ $11.00 | 763,636 | Oct 15, 2024 |
| Everest Aggregator, LP | — | Purchase | 1,363,636 @ $11.00 | 3,785,802 | Oct 15, 2024 |